
Opinion|Videos|May 15, 2024
Acalabrutinib-Based Treatment Clinical Trial Updates
Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CURE
1
Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch
2
6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You
3
FDA Approves Etcamah Plus CDK4/6 Inhibitor for ESR1-Mutated Breast Cancer
4
T-Cell Therapies Offer New Ways to Treat Lung Cancer
5




